21st North Inc Sustainability Reports
21st North Inc. (formerly Urologix, Inc.) developed, manufactured, and marketed minimally invasive medical devices for treating benign prostatic hyperplasia. Its core products included Cooled ThermoTherapy and the Prostiva RF Therapy System.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG001S8WCH9
1 reports from 2014 to 2014
Company Profile
21st North Inc. (formerly Urologix, Inc.) developed, manufactured, and marketed minimally invasive medical devices for treating benign prostatic hyperplasia. Its core products included Cooled ThermoTherapy and the Prostiva RF Therapy System.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years